# Flavopiridol in Treating Patients With Recurrent Prostate Cancer

> **NCT00003256** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 40 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** alvocidib

## Key facts

- **NCT ID:** NCT00003256
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-05
- **Primary completion:** 2002-07
- **Final completion:** 2004-04
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2013-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003256

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003256, "Flavopiridol in Treating Patients With Recurrent Prostate Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00003256. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*